Vaduganathan, Muthiah
Mehra, Mandeep R. http://orcid.org/0000-0001-8683-7044
Article History
First Online: 14 January 2020
Competing interests
: M.V. receives support from the KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst (NIH/NCATS Award UL 1TR002541), serves on advisory boards for Amgen, AstraZeneca, Baxter Healthcare, Bayer AG, Boehringer Ingelheim and Relypsa, and participates on clinical end point committees for studies sponsored by Novartis and the NIH. M.R.M. is a consultant for Abbott, Baim Institute for Clinical Research, Bayer AG, Fineheart, Janssen (a division of Johnson and Johnson), Leviticus, Medtronic, Mesoblast, NupulseCV, Portola and Triple Gene.